365 related articles for article (PubMed ID: 11321451)
1. Relaxation effect of nitric oxide-donor on diabetic penile smooth muscle in vitro.
Taher A; Birowo P; Kamil ST; Shahab N
Clin Hemorheol Microcirc; 2000; 23(2-4):277-81. PubMed ID: 11321451
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133
[TBL] [Abstract][Full Text] [Related]
3. NCX-911, a novel nitric oxide-releasing PDE5 inhibitor relaxes rabbit corpus cavernosum in the absence of endogenous nitric oxide.
Kalsi JS; Kell PD; Cellek S; Ralph DJ
Int J Impot Res; 2004 Apr; 16(2):195-200. PubMed ID: 14961060
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle.
Park K; Moreland RB; Goldstein I; Atala A; Traish A
Biochem Biophys Res Commun; 1998 Aug; 249(3):612-7. PubMed ID: 9731184
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro.
Chuang AT; Strauss JD; Murphy RA; Steers WD
J Urol; 1998 Jul; 160(1):257-61. PubMed ID: 9628660
[TBL] [Abstract][Full Text] [Related]
6. Effect of sildenafil and rolipram on adrenergic responses in isolated human and monkey corpus cavernosum.
Lau LC; Adaikan PG
Eur Urol; 2007 Jul; 52(1):253-8. PubMed ID: 17081675
[TBL] [Abstract][Full Text] [Related]
7. The effect of sildenafil on corpus cavernosal smooth muscle relaxation and cyclic GMP formation in the diabetic rabbit.
Thompson CS; Mumtaz FH; Khan MA; Wallis RM; Mikhailidis DP; Morgan RJ; Angelini GD; Jeremy JY
Eur J Pharmacol; 2001 Aug; 425(1):57-64. PubMed ID: 11672575
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
Firoozi F; Longhurst PA; White MD
BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142
[TBL] [Abstract][Full Text] [Related]
9. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
Saenz de Tejada I; Angulo J; Cuevas P; Fernández A; Moncada I; Allona A; Lledó E; Körschen HG; Niewöhner U; Haning H; Pages E; Bischoff E
Int J Impot Res; 2001 Oct; 13(5):282-90. PubMed ID: 11890515
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of penile tumescence by T-1032, a new potent and specific phosphodiesterase type V inhibitor, in dogs.
Noto T; Inoue H; Ikeo T; Kikkawa K
J Pharmacol Exp Ther; 2000 Sep; 294(3):870-5. PubMed ID: 10945835
[TBL] [Abstract][Full Text] [Related]
11. Rationale for the combination of PGE(1) and S-nitroso-glutathione to induce relaxation of human penile smooth muscle.
Angulo J; Cuevas P; Moncada I; Martín-Morales A; Allona A; Fernández A; Gabancho S; Ney P; Sáenz de Tejada I
J Pharmacol Exp Ther; 2000 Nov; 295(2):586-93. PubMed ID: 11046092
[TBL] [Abstract][Full Text] [Related]
12. A novel compound JPM8: in vivo penile activity promotion in rats, effect on the relaxation and cGMP/cAMP accumulation in isolated rabbit corpora cavernosa.
El-Thaher TS; Khatib S; Saleem M; Shnoudeh A; Badwan AA
Int J Impot Res; 2002 Dec; 14(6):453-61. PubMed ID: 12494277
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo effects of vardenafil (a PDE-5 Inhibitor) on corpus cavernosal smooth muscle relaxation in diabetic rabbits.
Lau DH; Mumtaz FH; Mikhailidis DP; Thompson CS
Urol Int; 2009; 82(1):101-7. PubMed ID: 19172107
[TBL] [Abstract][Full Text] [Related]
14. Epimedium brevicornum Maxim extract relaxes rabbit corpus cavernosum through multitargets on nitric oxide/cyclic guanosine monophosphate signaling pathway.
Chiu JH; Chen KK; Chien TM; Chiou WF; Chen CC; Wang JY; Lui WY; Wu CW
Int J Impot Res; 2006; 18(4):335-42. PubMed ID: 16395327
[TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide in the relaxation elicited by sildenafil in penile resistance arteries.
Prieto D; Rivera L; Recio P; Rubio JL; Hernández M; García-Sacristán A
J Urol; 2006 Mar; 175(3 Pt 1):1164-70. PubMed ID: 16469645
[TBL] [Abstract][Full Text] [Related]
16. Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model.
De Young L; Yu D; Freeman D; Brock GB
Int J Impot Res; 2003 Oct; 15(5):347-54. PubMed ID: 14562136
[TBL] [Abstract][Full Text] [Related]
17. Effects of NCX 4050, a new NO donor, in rabbit and human corpus cavernosum.
Filippi S; Crescioli C; Vannelli GB; Fazzini A; Natali A; Riffaud JP; Maggi M; Ledda F
Int J Androl; 2003 Apr; 26(2):101-8. PubMed ID: 12641828
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of PDE5 inhibition in erectile dysfunction.
Corbin JD
Int J Impot Res; 2004 Jun; 16 Suppl 1():S4-7. PubMed ID: 15224127
[TBL] [Abstract][Full Text] [Related]
19. Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats.
Bivalacqua TJ; Usta MF; Champion HC; Leungwattanakij S; Dabisch PA; McNamara DB; Kadowitz PJ; Hellstrom WJ
Int J Impot Res; 2004 Feb; 16(1):21-9. PubMed ID: 14963467
[TBL] [Abstract][Full Text] [Related]
20. Intracavernosal sildenafil facilitates penile erection independent of the nitric oxide pathway.
McAuley IW; Kim NN; Min K; Goldstein I; Traish AM
J Androl; 2001; 22(4):623-8. PubMed ID: 11451359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
